Search Results

Keywords: synthetic

England’s health insurance has covered only 18 ‘unlicensed’ cannabis prescriptions

November 19, 2019

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. In the case of private prescriptions – which are paid out of pocket by patients – the number of prescriptions reached 104. The data […]

Read More

Week in Review: Cannabis layoffs, regulators scrutinizing vitamin E acetate as vape villain, MI adult-use launch looms & more

November 15, 2019 · Updated November 18, 2019

Layoff announcements continue to weigh on the marijuana industry, state regulators focus on vitamin E acetate additive in vaporizer products as the vape crisis continues, Michigan businesses set their game plans for a December adult-use MJ launch, and more of the week’s top cannabis news. Pink slips pile up  Three well-known California cannabis companies this […]

Read More

Wellness products take off in the growing recreational cannabis market

October 1, 2019 · Updated June 6, 2021

Is the U.S. medical marijuana industry doomed? Amid news reports suggesting that MMJ markets are plateauing or shrinking in some states—particularly those that have approved the recreational use of marijuana, it’s reasonable to believe cannabis executives are bailing out of medical and plowing resources into adult-use products. Not so. Many cannabis companies are doubling down […]

Read More

The Battle Is Set: Human-Made versus Natural Cannabinoids

October 1, 2019 · Updated October 13, 2021

Of all the forces that will shape the future of medical marijuana, the rise of biosynthetic cannabinoids stands to be among the most disruptive—one that could pose a major competitive threat to medicine derived from the cannabis plant. But the extent and timing of that threat depends on a few factors. Several companies say they […]

Read More

Global Cannabis: Brazil

September 4, 2019

Milestones in the Medical Cannabis Program The National Sanitary Surveillance Agency regulated “compassionate use” imports in 2015.   Key Laws and Regulations RDC No. 17/2015 Portaria 344/1998   Market Data Since 2014, almost 10,000 authorizations were granted to individual patients, allowing them to import medical cannabis on a case-by-case basis, each for a period of […]

Read More

Growing Momentum: Brazil

September 2, 2019 · Updated June 6, 2021

Milestones in the Medical Cannabis Program The National Sanitary Surveillance Agency regulated “compassionate use” imports in 2015.   Key Laws and Regulations RDC No. 17/2015 Portaria 344/1998   Market Data Since 2014, almost 10,000 authorizations were granted to individual patients, allowing them to import medical cannabis on a case-by-case basis, each for a period of […]

Read More

Brazilian health regulators mull plan for cannabis cultivation and products, but proposal draws opposition

August 2, 2019 · Updated November 4, 2019

Brazilian health regulators are weighing a landmark plan to permit the domestic cultivation of marijuana and the registration of medical cannabis products that have not yet completed clinical trials, a move that would open a potentially huge market to MJ companies from around the globe. But the proposed rules have encountered stiff opposition from a […]

Read More

Craft Cannabis: The Art of Cultivating

August 1, 2019 · Updated June 6, 2021

Nearly every marijuana cultivator wants to call its cannabis craft. Whether the plant is grown indoors or outside, with a hydroponic irrigation system or a watering can, under the sun or high-tech LED lights, few growers want their flower to be considered corporate cannabis. A marijuana company that appeals to the masses on a large […]

Read More

Bipartisan lawmakers offer congressional bill to promote cannabis, CBD research

June 28, 2019 · Updated July 2, 2019

A bipartisan group of U.S. senators introduced a federal bill to bolster marijuana and CBD research, a move that could encourage more doctors to recommend medical cannabis and expand legalization efforts. The bill also would amend the definition of marijuana in the federal Controlled Substances Act to exclude the synthetic equivalent of hemp-derived CBD that […]

Read More

Surterra partners with Intrexon in $100 million licensing cannabinoid deal

June 18, 2019 · Updated June 19, 2019

Surterra Wellness, an Atlanta-based cannabis company with operations in Florida and Texas, announced it will partner with Hungary’s Intrexon Corp. in a $100 million licensing deal aimed at biosynthetic cannabinoid production. Surterra would use Intrexon’s proprietary yeast fermentation platform to boost its cannabinoid production. Surterra is a privately held company; Intrexon trades on the Nasdaq […]

Read More

Breakthrough in Brazil: Regulators eye domestic cannabis cultivation, creation of product registration plan

June 17, 2019 · Updated June 18, 2019

Brazil could become the latest country to regulate the domestic cultivation of medical cannabis, according to the government body responsible for regulating marijuana – a move that will have major implications for the industry when the rules take effect. At a public meeting last week, the National Sanitary Surveillance Agency (ANVISA) collegiate directors approved two draft […]

Read More